FOF/VC  Renaissance Venture Capital Fund

http://www.renvcf.com





     Office Locations:

201 South Main Street, 10th Floor
Ann Arbor, MI 48104
Phone: 734-997-8661

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology

  •  

    Description:

    The Renaissance Venture Capital Fund is a Michigan-based fund of funds that supports the growth of venture capital in Michigan. Through its investment in top tier venture firms that are active in Michigan, as well as its own co-investments in emerging Michigan companies, the Renaissance Venture Capital Fund is helping to drive forward both innovation and growth of emerging companies in the region.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher L. Rizik Chief Executive Officer and Fund Manager
    Jeffrey Rinvelt Principal
    Kristopher Wiljanen Director of Business Development

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/14/2017


      Cirius Therapeutics


      


      $40,000,000


      Series A


     

    Portfolio companies include:


      5AM Ventures
        web link


      Arboretum Ventures
        web link


      ArborMetrix
        web link


      Arsenal Venture Partners
        web link


      Cirius Therapeutics
        web link


      DFJ Mercury
        web link


      Flagship Ventures
        web link


      HIG Bioventures
        web link


      MK Capital
        web link


      RPM Ventures
        web link


      Swift Biosciences
        web link


      TGap Ventures
        web link


     

    Recent News: